Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

2615 results

Sort By:

Surgery and Laser Interstitial Thermal Therapy for Bilateral Glioblastomas

Study ID: NCT07384884
Start Date: 2026-03-01
End Date: 2027-07-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

12

Intervention / Treatment

surgery (any volume) and / or pharmaceuticals treatment initiated or planned or only dynamic observation, in accordance with current clinical guidelines

Sponsor

King's College Hospital NHS Trust

Source: clinicaltrials.gov

Share:
Add to list

IV Injection of Metoclopramide With or Without Dexamethasone

Study ID: NCT07343817
Start Date: 2026-07-01
End Date: 2028-04-01
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

1

Intervention / Treatment

Dexamethasone

Ultrasonography assessment

Sponsor

Ahmed Nassar Ibrahim Mohammed

Source: clinicaltrials.gov

Share:
Add to list

Minimally Invasive Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Cancer, SOS5C Trial

Study ID: NCT07206589
Start Date: 2026-03-01
End Date: 2027-10-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

1010

Intervention / Treatment

Cancer Screening

Computer-Assisted Intervention

Endoscopic Procedure

Health Risk Assessment

Navigation

Administration Questionnaire

Sponsor

Mayo Clinic

Source: clinicaltrials.gov

Share:
Add to list

Long-term Stability of Peri-implantitis Treatments: a 3-year Clinical Evaluation

Study ID: NCT07208643
Start Date: 2026-04-01
End Date: 2026-05-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

34

Intervention / Treatment
Sponsor

Ramón Pons Calabuig

Source: clinicaltrials.gov

Share:
Add to list

A Study to Investigate the Long-term Safety, Tolerability and Efficacy of Balinatunfib in Participants With Crohn's Disease or Ulcerative Colitis (SPECIFI-IBD-LTS)

Study ID: NCT07222189
Start Date: 2026-05-12
End Date: 2030-05-10
Study Type

Interventional

Study Phase

Phase2

No. of Participants

325

Intervention / Treatment

balinatunfib

balinatunfib-matching placebo

Sponsor

Sanofi

Source: clinicaltrials.gov

Share:
Add to list

Prospective National Cohort Evaluating Prognostic Factors for Efficacy of Fruquintinib Treatment in Patients With Metastatic Colorectal Cancer

Study ID: NCT07124858
Start Date: 2026-03-01
End Date: 2031-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

300

Intervention / Treatment

Fruquintinib

Sponsor

French-speaking Federation of Digestive Cancerology

Source: clinicaltrials.gov

Share:
Add to list

Exercise in Perimenopause to Improve Cognitive Health

Study ID: NCT07272174
Start Date: 2026-03-01
End Date: 2027-01-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

Progressive Resistance Training

Balance, Flexibility, and Tone Exercises

Sponsor

University of British Columbia

Source: clinicaltrials.gov

Share:
Add to list

Neuroproprioceptive Equine-Assisted Physiotherapy for Spinal Muscular Atrophy

Study ID: NCT07336602
Start Date: 2026-04-15
End Date: 2026-06-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment

Equine-Assisted Physiotherapy based on Neuro-proprioceptive "Facilitation and Inhibition"

Standard Individual Outpatient Physiotherapy Based on Neuro-proprioceptive Facilitation and Inhibition

Therapeutic grooming

Sponsor

Charles University, Czech Republic

Source: clinicaltrials.gov

Share:
Add to list

From Conflict to Family Trauma

Study ID: NCT07134322
Start Date: 2026-02-08
End Date: 2026-12-20
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

200

Intervention / Treatment

The aim of this research is to record how many families go to court for the breakdown of parent-child relationships and to understand how many of these families, one year after the judge's ruling, hav

Sponsor

University of Bari Aldo Moro

Source: clinicaltrials.gov

Share:
Add to list

EBV-Tscm Cytotoxic T Cells (CTLs) for EBV- Driven Lymphomas/ Diseases

Study ID: NCT05688241
Start Date: 2026-11
End Date: 2031-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

10

Intervention / Treatment

Donor-derived ex-vivo expanded EBV Tscm CTL

Sponsor

University Hospital, Basel, Switzerland

Source: clinicaltrials.gov

Share:
Add to list